Cargando…

Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases

BACKGROUND: The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yanting, Xu, Jianteng, Xie, Anni, Liu, Sijia, Wang, Xiaojian, Zhu, Runzhang, Wang, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089424/ https://www.ncbi.nlm.nih.gov/pubmed/34192120 http://dx.doi.org/10.1159/000515278

Ejemplares similares

Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19
por: Padilla, Sergio, et al.
Publicado: (2020)

ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021)

Local Anesthetic Like Inhibition of the Cardiac Na(+) Channel Nav1.5 by Chloroquine and Hydroxychloroquine
por: Hage, Axel, et al.
Publicado: (2022)

Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Assessment of Urinary Exosomal NHE3 as a Biomarker of Acute Kidney Injury
por: Yu, Yanting, et al.
Publicado: (2022)

Serious cardiac AEs with hydroxychloroquine during COVID-19 pandemic
Publicado: (2020)

Hydroxychloroquine Alleviates EAU by Inhibiting Uveitogenic T Cells and Ameliorating Retinal Vascular Endothelial Cells Dysfunction
por: Hu, Yunwei, et al.
Publicado: (2022)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
por: Yuan, Zixuan, et al.
Publicado: (2020)

Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons
por: Rother, Nils, et al.
Publicado: (2020)

Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)

Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial
por: Eveleens Maarse, Boukje C., et al.
Publicado: (2021)

How to characterize figures of merit of two-dimensional photodetectors
por: Wang, Fang, et al.
Publicado: (2023)

Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020)

Pro-inflammatory Ca(++)-activated K(+) channels are inhibited by hydroxychloroquine
por: Eugenia Schroeder, María, et al.
Publicado: (2017)

Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
por: Fram, Georgi, et al.
Publicado: (2021)

Obesity and Cardiac Conduction Block Disease in China
por: Liu, Peipei, et al.
Publicado: (2023)

Cardiac conduction disturbances and aging in patients with Duchenne muscular dystrophy
por: Segawa, Kazuhiko, et al.
Publicado: (2017)

Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
por: Lo, Chien-Hsien, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac disorder followed by off-label use: case report
Publicado: (2020)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
por: Yendrapalli, Usha, et al.
Publicado: (2021)

COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases
por: Raza, Hussain Ahmed, et al.
Publicado: (2021)

Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths
por: Padiyar, Shivraj, et al.
Publicado: (2021)

Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren’s Syndrome
por: Yang, Deng-Ho, et al.
Publicado: (2020)

Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer
por: Patel, Sukeshi, et al.
Publicado: (2016)

Synergistic Effect of Zinc-Chitosan Nanoparticles and Hydroxychloroquine to Inhibit Buffalo Coronavirus
por: Manuja, Anju, et al.
Publicado: (2023)

Cardiac conduction defects
por: Guerri, Giulia, et al.
Publicado: (2019)

Anisotropic Cardiac Conduction
por: Kotadia, Irum, et al.
Publicado: (2020)

Hydroxychloroquine-induced erythroderma
por: Pai, Sunil B., et al.
Publicado: (2017)

Science, Politics and Hydroxychloroquine
por: Somberg, John
Publicado: (2020)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Hyperpigmentation Induced by Hydroxychloroquine
por: Hamri, Laila
Publicado: (2023)

Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
por: Lo, Chien-Hsien, et al.
Publicado: (2021)

Recurrent Kikuchi's Disease Treated by Hydroxychloroquine
por: Hyun, Miri, et al.
Publicado: (2016)

Hydroxychloroquine: small effects in mild disease
por: Levantovsky, Rachel, et al.
Publicado: (2020)

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
por: Liu, Jia, et al.
Publicado: (2020)

An MMP-degradable and conductive hydrogel to stabilize HIF-1α for recovering cardiac functions
por: Wei, Xiaojuan, et al.
Publicado: (2022)

Azithromycin/hydroxychloroquine: Cardiac disorders following off label use: 5 case reports
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_86sb1chpk2023u5d4rlmphuhbi